Although primarily used to reduce gluconeogenesis and increase insulin sensitivity in patients with type 2 diabetes, some, but not all, observational studies have reported lower incidence of breast cancer among diabetic patients taking metformin (157–159). The gene discussed is INS; the disease is breast carcinoma.